As of April 14, 2023, the ordinary ranking bestowed on AvalonBay Communities, Inc. (NYSE:AVB) by twenty-1 economical analysts is a “Hold,” studies Bloomberg.com. Though two financial commitment analysts issued a provide ranking, eleven remained neutral and five have rated the enterprise as a acquire. The average 12-month goal rate between […]

On April 5, 2023, Bloomberg.com described that Keros Therapeutics, Inc. (NASDAQ:KROS) acquired an common score of “Buy” from the 6 ratings corporations that protect the firm. The optimistic sentiment is attributed to the five financial commitment analysts who have provided a acquire advice for the inventory. Keros Therapeutics, Inc. is […]